NCT06612086View on ClinicalTrials.gov

Dapagliflozin in Mangement of Pulmonary Hypertension Patients

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 25, 2024

Primary Completion Date

September 10, 2025

Study Completion Date

October 10, 2026

Conditions
Pulmonary Hypertension
Interventions
DRUG

Dapagliflozin (Forxiga)

we study effect of dapagliflozin on patient with pulmonary hypertension by follow up RV function and prognosis of life of patient

Trial Locations (1)

Unknown

Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT06612086 - Dapagliflozin in Mangement of Pulmonary Hypertension Patients | Biotech Hunter | Biotech Hunter